rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGAGTCAGTCGCTTAAATCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	84	0.027018333869411385		49	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	3	4	5	2	4	10	29	43	50	47	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAACAAGGGCGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQTRAAGANVLTF	In	VDJ	3	191	0.061434544869733036	0.08124202467035305	48	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-06	01	2	5	3	2	3	3	29	44	51	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQTRAAGANVLTF+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01		TCRBJ02-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCATGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSAWDSNQPQHF	In	VDJ	1	20	0.0064329366355741395	0.008507018290089324	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-05	01	5	0	8	0	4	0	24	36	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAWDSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01		TCRBJ01-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTGGCTTAAGAAGGACTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	58	0.018655516243165006		55	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	1	10	4	12	11	24	35	52	47	63						01,02								X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGACCCGATAGCGGGGGGGATGTTCTTCGGGCCA	CASSLDPIAGGMFF	In	VDJ	1	21	0.006754583467352846	0.00893236920459379	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	5	0	15	8	2	19	33	52	41	54														CASSLDPIAGGMFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCACCTCATCAGGGATGGGCGACGAGCAGTACTTCGGGCCG	CASTSSGMGDEQYF	In	VDJ	1	23	0.007397877130910261	0.009783071033602722	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	3	5	8	7	19	27	40	35	47														CASTSSGMGDEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGTGCAGGGGGTCTCACAGATACGCAGTATTTTGGCCCA	CASSEGAGGLTDTQYF	In	VDJ	1	57	0.0183338694113863	0.024245002126754574	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	1	2	3	3	23	39	49	42	52														CASSEGAGGLTDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-03*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGGGACACAGATACGCAGTATTTTGGCCCA	CAWSVGDTDTQYF	In	VDJ	1	29	0.009327758121582503	0.01233517652062952	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	0	6	1	2	0	1	26	-1	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGDTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGACAGCTGGTCACTGAAGCTTTCTTTGGACAA	CAWSVGQLVTEAFF	In	VDJ	1	36	0.011579285944033452	0.015312632922160783	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	5	4	0	5	26	-1	47	40	52													Vb 20	CAWSVGQLVTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTGTTGTCAGGGGGGAATTATGGCTACACCTTCGGTTCG	CALLSGGNYGYTF	In	VDJ	1	63	0.02026375040205854	0.02679710761378137	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	1	5	6	4	26	33	46	39	50			unresolved										Vb 20	CALLSGGNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCACGATTATTATCTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	22	0.007076230299131554		52	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	13	5	22	31	49	44	54														X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCATTGTGGATTTCTGGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	0.008684464458025088		47	TCRBV17	TCRBV17-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	4	13	5	22	31	48	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV17-01+TCRBJ01-02	TCRBV17-01*01		TCRBJ01-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGCCTGCGGGTGGGACCCAGTACTTCGGGCCA	CASSWPAGGTQYF	In	VDJ	1	30	0.00964940495336121	0.012760527435133985	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	7	4	7	5	3	25	38	48	43	51						01,02							Vb 3	CASSWPAGGTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGGCAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASKAGSGANVLTF	In	VDJ	1	33	0.01061434544869733	0.014036580178647383	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	4	4	0	3	0	25	35	-1	38	42													Vb 3	CASKAGSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATACCGGGACGGAAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLYRDGNSNQPQHF	In	VDJ	1	35	0.011257639112254744	0.014887282007656316	51	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	1	0	7	0	3	5	25	41	49	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLYRDGNSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGTAACGGCTATGAAAAACTGTTTTTTGGCAGT	CASSLGNGYEKLFF	In	VDJ	1	56	0.018012222579607592	0.023819651212250107	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	2	9	0	6	6	1	25	40	49	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGNGYEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGACTACCTGTGGCAGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASSGLPVAGRNTEAFF	In	VDJ	1	25	0.008041170794467674	0.010633772862611655	51	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	4	4	3	1	12	2	23	36	53	48	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSGLPVAGRNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCACTCCGTGGAGGGGAATGGAACACTGAAGCTTTCTTTGGACAA	CASTPLRGGEWNTEAFF	In	VDJ	1	25	0.008041170794467674	0.010633772862611655	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	10	0	1	11	5	27	37	54	48	59			01,02										Vb 17	CASTPLRGGEWNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAGAAAGGGGGGCTCGGGCAGCCCCAGCATTTTGGTGAT	CASEKGGLGQPQHF	In	VDJ	1	26	0.008362817626246381	0.01105912377711612	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	8	5	1	7	5	7	27	36	47	41	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASEKGGLGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTAGGCGGACGGCGGAGCGAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CATRRTAERSSYNSPLHF	In	VDJ	1	40	0.012865873271148279	0.017014036580178648	54	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	6	1	7	0	2	12	27	38	44	40	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATRRTAERSSYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAACCTCGCCTCGGCGGCTAGCGGAGAAGAGACCCAGTACTTCGGGCCA	CANLASAASGEETQYF	In	VDJ	1	43	0.0138308137664844	0.018290089323692044	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	4	5	3	15	2	27	34	56	49	58			01,02			01,02							Vb 17	CANLASAASGEETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTACTTGACCACAGATACGCAGTATTTTGGCCCA	CASSIYLTTDTQYF	In	VDJ	1	87	0.02798327436474751	0.03700552956188856	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	2	7	2	6	0	27	41	-1	47	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIYLTTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGACCTAGCGGGTTGGTAGAATGAGCAGTTCTTCGGGCCA	CSVEDLAGW*NEQFF	Stop	VDJ	1	30	0.00964940495336121		45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	4	7	1	7	25	39	48	40	55						01,02							Vb 4	CSVEDLAGW*NEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGAACGCTACAGGGCCGGACAGGGGGCCCCTAAATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	0.007397877130910261		53	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	1	0	6	14	6	23	31	56	45	62		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTATTCCCCAGCTTACGAGCAGTACTTCGGGCCG	CASSYSPAYEQYF	In	VDJ	1	25	0.008041170794467674	0.010633772862611655	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	3	4	5	4	5	2	23	37	45	42	47		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSPAYEQYF+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGATCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	0.006111289803795433		46	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	2	8	5	1	14	26	38	41	39	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTTCAGCGGGGCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLQRGTNTGELFF	In	VDJ	1	20	0.0064329366355741395	0.008507018290089324	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	6	3	0	4	2	26	38	49	42	51		TCRBV12-03,TCRBV12-04												CASSLQRGTNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAAACTGAGCCGGAGGACCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	0.006754583467352846		55	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	1	0	11	3	26	43	59	54	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTACATTTCCCATTTCCACCGACAATGAGCAGTTCTTCGGGCCA	CASSLTFPISTDNEQFF	In	VDJ	1	23	0.007397877130910261	0.009783071033602722	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	6	5	2	16	26	39	44	41	60		TCRBV03-01,TCRBV03-02												CASSLTFPISTDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAGACGGGCCCGGCACTATGGCTACACCTTCGGTTCG	CASSQDRRARHYGYTF	In	VDJ	1	25	0.008041170794467674	0.010633772862611655	48	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	8	0	3	5	5	26	43	52	48	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRRARHYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGGTAGTGTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	0.008041170794467674		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	3	17	26	38	44	41	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGTTATAGACTTTTCCAAGAGACCCAGTACTTCGGGCCA	CASSYRLFQETQYF	In	VDJ	1	25	0.008041170794467674	0.010633772862611655	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	2	10	1	5	3	19	30	39	35	42		TCRBV05-06,TCRBV05-07				01,02								CASSYRLFQETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD02-01	TCRBJ02-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGACAGTAACTACGAGCAGTACTTCGGGCCG	CSASDSNYEQYF	In	VDJ	1	26	0.008362817626246381	0.01105912377711612	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	5	3	1	3	26	37	43	38	46		TCRBV20-01,TCRBV20-or09_02												CSASDSNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGCGATGGGCCAGATACGCAGTATTTTGGCCCA	CSACDGPDTQYF	In	VDJ	1	26	0.008362817626246381	0.01105912377711612	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	4	6	0	26	35	-1	41	45		TCRBV20-01,TCRBV20-or09_02												CSACDGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCCTCAAGGTTTGCGGGGGGGCCTAGGGAGACCCAGTACTTCGGGCCA	CSASRFAGGPRETQYF	In	VDJ	1	28	0.009006111289803796	0.011909825606125054	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	9	7	0	5	13	6	26	31	53	44	59		TCRBV20-01,TCRBV20-or09_02												CSASRFAGGPRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCAAGTTGGGACCAGAACTACGAGCAGTACTTCGGGCCG	CSASASWDQNYEQYF	In	VDJ	1	28	0.009006111289803796	0.011909825606125054	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	0	7	3	8	5	26	37	50	45	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASASWDQNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCGTAAAGATCAGGGCGGGGAGCTGTTTTTTGGAGAA	CASSRKDQGGELFF	In	VDJ	1	30	0.00964940495336121	0.012760527435133985	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	7	9	0	19	31	-1	40	45	TCRBV05,TCRBV07													CASSRKDQGGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGACCGTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSDRNSNQPQHF	In	VDJ	1	30	0.00964940495336121	0.012760527435133985	42	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	6	2	7	0	1	5	24	35	39	36	44	TCRBV02,TCRBV21			TCRBD01,TCRBD02										CASSDRNSNQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGTGGACGTTGTCACAGATACGCAGTATTTTGGCCCA	CASSQGVDVVTDTQYF	In	VDJ	1	32	0.010292698616918623	0.013611229264142918	48	TCRBV03						TCRBJ02	TCRBJ02-03	01	1	1	7	2	4	5	26	42	50	46	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVDVVTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGAGGGTTCATTAGCTGCGAACACTGAAGCTTTCTTTGGACAA	CASSEGSLAANTEAFF	In	VDJ	1	32	0.010292698616918623	0.013611229264142918	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	1	0	12	24	-1	41	36	53	TCRBV12,TCRBV21													CASSEGSLAANTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCCCATTTCCCATACATCATAATTCACCCCTCCACTTTGGGAAC	CASSRPFPIHHNSPLHF	In	VDJ	1	33	0.01061434544869733	0.014036580178647383	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	6	5	13	2	26	39	55	52	57		TCRBV03-01,TCRBV03-02												CASSRPFPIHHNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGCAAGATACGCAGGGAACACTGAAGCTTTCTTTGGACAA	CSAGARYAGNTEAFF	In	VDJ	1	35	0.011257639112254744	0.014887282007656316	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	7	0	1	0	12	26	-1	40	35	52		TCRBV20-01,TCRBV20-or09_02												CSAGARYAGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAGCGGGACACAACTAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSSGTQLSSYNSPLHF	In	VDJ	1	39	0.012544226439369572	0.01658868566567418	54	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	6	3	0	0	10	26	-1	45	38	55		TCRBV12-03,TCRBV12-04												CASSSGTQLSSYNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01*02	TCRBJ01-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTCTAGCGGGGAATACGCAGTATTTTGGCCCA	CSARALAGNTQYF	In	VDJ	1	39	0.012544226439369572	0.01658868566567418	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	4	3	7	2	1	26	39	50	41	51		TCRBV20-01,TCRBV20-or09_02												CSARALAGNTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCGTTTCTAGCGGGAAAGTACTATAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	43	0.0138308137664844		59	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	4	3	0	8	9	22	33	50	41	59		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01*02	TCRBJ02-04*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACTCGGGAGCCGGGGAGCTGTTTTTTGGAGAA	CSANSGAGELFF	In	VDJ	1	44	0.014152460598263108	0.01871544023819651	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	8	2	6	3	0	26	36	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSANSGAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCACCGGGGCCACTGGAATGAACACTGAAGCTTTCTTTGGACAA	CASSRTGATGMNTEAFF	In	VDJ	1	48	0.015439047925377935	0.020416843896214378	51	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	7	0	0	5	8	26	39	49	44	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTGATGMNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTAGCCATGATTCCCTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	55	0.017690575747828882		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	6	7	0	0	12	24	-1	39	36	51	TCRBV06,TCRBV10					01,02								X+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATATCCGGGCAGCTTTATCTTATGGCTACACCTTCGGTTCG	CASSQDIRAALSYGYTF	In	VDJ	1	62	0.019942103570279833	0.026371756699276903	51							TCRBJ01	TCRBJ01-02	01	0	8	0	5	5	10	18	35	44	40	54	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDIRAALSYGYTF+X+TCRBJ01-02			TCRBJ01-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGATCTGGGGGCGGTCTCCGGGGAGCTGTTTTTTGGAGAA	CASSQDLGAVSGELFF	In	VDJ	1	72	0.023158571888066904	0.030625265844321566	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	6	0	6	3	5	23	40	49	43	54	TCRBV04,TCRBV23													CASSQDLGAVSGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGAATGGTCCCCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	78	0.025088452878739145		49	TCRBV03						TCRBJ02	TCRBJ02-01	01	4	0	10	5	5	12	26	39	46	44	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSLAGGNTEAFF	In	VDJ	1	87	0.02798327436474751	0.03700552956188856	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	1	2	0	1	26	-1	49	43	50		TCRBV12-03,TCRBV12-04												CASSLAGGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCCCCGGGACAGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSQAPGTGTSTDTQYF	In	VDJ	2	93	0.02991315535541975	0.03955763504891536	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	3	0	5	3	26	42	56	47	59		TCRBV03-01,TCRBV03-02												CASSQAPGTGTSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAGCCAGACCTATCTGTACCACTGTGGCAGTTCAATGATGTGAGCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	36	0.011579285944033452		52	TCRBV08	TCRBV08-02	01				TCRBJ02	TCRBJ02-06	01	6	3	6	5	16	5	22	30	49	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV08-02+TCRBJ02-06	TCRBV08-02*01		TCRBJ02-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGTATGCGAGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	0.010292698616918623		41	TCRBV22	TCRBV22-01	01				TCRBJ01	TCRBJ01-02	01	5	2	7	4	11	0	25	36	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV22-01+TCRBJ01-02	TCRBV22-01*01		TCRBJ01-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGGACACGTCGCGAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CPGRTRREQSRANVLTF	In	VDJ	2	95	0.030556449018977163	0.040408336877924285	51	TCRBV22	TCRBV22-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	0	16	25	-1	40	36	56														CPGRTRREQSRANVLTF+TCRBV22-01+TCRBJ02-06	TCRBV22-01*01	TCRBD01-01*01	TCRBJ02-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAATAAAAAGGACTAGCGGGAAATGTCGGGGAGCTGTTTTTTGGAGAA	CASSQE*KGLAGNVGELFF	Stop	VDJ	1	25	0.008041170794467674		57	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	1	3	7	7	5	23	40	59	47	64													Vb 7.1	CASSQE*KGLAGNVGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTGGACGGGGACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDWTGTSYNEQFF	In	VDJ	1	33	0.01061434544869733	0.014036580178647383	51	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-01	01	0	0	7	0	7	0	23	40	-1	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDWTGTSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01		TCRBJ02-01*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTACGGGGAGGCAAAAACATTCAGTACTTCGGCGCC	CASSLVRGGKNIQYF	In	VDJ	1	28	0.009006111289803796	0.011909825606125054	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	9	1	3	4	0	18	34	-1	38	44														CASSLVRGGKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-04*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCCTGCTAGGCTGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	31	0.009971051785139916		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	4	8	4	7	11	18	30	41	37	52						01,02								X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGTGGGGGGGCCGGTGAGACCCAGTACTTCGGGCCA	CASSPGGGAGETQYF	In	VDJ	1	42	0.013509166934705693	0.01786473840918758	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	9	0	5	6	5	18	30	43	36	48														CASSPGGGAGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGAACAGCTAAATCTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	61	0.019620456738501126		56	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	5	5	2	17	18	31	37	33	54														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTAAACGGGGGGTTCCTATACGAGCAGTACTTCGGGCCG	CASSLNGGFLYEQYF	In	VDJ	1	21	0.006754583467352846	0.00893236920459379	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	1	4	6	6	20	31	44	37	50														CASSLNGGFLYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-07*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAAATCCTCCGGGACAGGGGGCGGACGAGCAGTACTTCGGGCCG	CASSQNPPGQGADEQYF	In	VDJ	1	32	0.010292698616918623	0.013611229264142918	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	0	5	8	2	20	35	55	43	57														CASSQNPPGQGADEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGGGTGGGGGAGTCCCTACGAGCAGTACTTCGGGCCG	CASKGWGSPYEQYF	In	VDJ	1	22	0.007076230299131554	0.009357720119098255	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	7	5	2	2	0	10	23	-1	38	33	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKGWGSPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGTGGGACCATGGAGACCCAGTACTTCGGGCCA	CASSRGTMETQYF	In	VDJ	1	23	0.007397877130910261	0.009783071033602722	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	7	5	3	4	23	35	43	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGTMETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGACCAAAATCCCTACGAGCAGTACTTCGGGCCG	CASSWDQNPYEQYF	In	VDJ	1	27	0.008684464458025088	0.011484474691620587	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	0	7	2	0	7	23	-1	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWDQNPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTTTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	32	0.010292698616918623		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	3	1	2	0	23	40	-1	42	50														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTGCACAGCGTAGATACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CAISCTA*IQSRANVLTF	Stop	VDJ	1	56	0.018012222579607592		54	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	4	3	5	5	2	15	23	36	42	38	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISCTA*IQSRANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGTACTAGCGGGAGGATTGAAAAACTGTTTTTTGGCAGT	CASSGTSGRIEKLFF	In	VDJ	1	42	0.013509166934705693	0.01786473840918758	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	3	1	7	3	2	24	36	51	39	53													Vb 18	CASSGTSGRIEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-04*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGACAGGGGGCTGAAAAACTGTTTTTTGGCAGT	CASSPPGQGAEKLFF	In	VDJ	1	76	0.02444515921518173	0.03232666950233943	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	0	7	0	0	24	-1	-1	41	53													Vb 18	CASSPPGQGAEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPPTGANVLTF	In	VDJ	1	83	0.02669668703763268	0.03530412590387069	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	0	2	8	2	0	0	24	-1	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPTGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCGGACAGGGCAATGAAAAACTGTTTTTTGGCAGT	CASSPPGQGNEKLFF	In	VDJ	1	85	0.027339980701190092	0.036154827732879626	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	3	5	4	1	24	38	50	42	51													Vb 18	CASSPPGQGNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	5219A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				77	58	16	2	0	73	54	16	3	0	3109	2351	647	111	0	0.0422398821	5.51180172	0.0359280445	5.96743631				1187	0.0429639071	0.0812420249	0.0614345446	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:22	Age (Range):45-65 Years (Late Adulthood),Age:61 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 625,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 306,type of chemo:carbo/taxol	0.7532467327159422	MSKCC- Snyder- P01-02		51.0	
